Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Curevac N.V.
(NQ:
CVAC
)
3.100
+0.060 (+1.97%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Curevac N.V.
< Previous
1
2
3
4
5
6
7
Next >
CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
July 03, 2024
CureVac layoffs are coming for 30% of the vaccine company's employees as it prepares for a restructuring that will save it over 30% in costs.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
GOEV Stock: Canoo Receives Fleet Order From Go2 Delivery
July 03, 2024
Canoo stock is down on Wednesday as GOEV investors appear unimpressed by the company's new delivery van fleet deal with Go2 Delivery.
Via
InvestorPlace
DM Stock Alert: Nano Dimension Is Scooping Up Desktop Metal for $183 Million
July 03, 2024
Desktop Metal stock is up on Wednesday as DM investors learn of an acquisition deal with Nano Dimension for the company's shares.
Via
InvestorPlace
CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
July 03, 2024
CureVac stock is up on Wednesday as CVAC investors react to the company signing a new 1.4 billion euro licensing agreement with GSK.
Via
InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
GSK and CureVac restructured their collaboration into a new licensing agreement, prioritizing mRNA vaccine development. GSK gains full control of vaccine candidates for influenza and COVID-19, while...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Insights into CureVac's Upcoming Earnings
November 11, 2024
Via
Benzinga
GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza mRNA Vaccine
September 12, 2024
GSK announced positive phase 2 trial results for its mRNA seasonal flu vaccine, showing strong immune.
Via
Benzinga
CVAC Stock Earnings: CureVac Misses EPS, Beats Revenue for Q2 2024
August 20, 2024
CVAC stock results show that CureVac missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q1 2024
July 12, 2024
CVAC stock results show that CureVac missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Southwest Airlines Adopts a Poison Pill Plan: 7 Things to Know
July 03, 2024
Southwest Airlines is in the news Wednesday after the airline company adopted a poison pill to battle activist investor Elliott Management.
Via
InvestorPlace
Why Is DouYu (DOYU) Stock Up 44% Today?
July 03, 2024
DouYu stock is up on Wednesday after the company announced a special cash dividend for DOYU investors payable in August.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 03, 2024
Pre-market stock movers are worth checking out on Wednesday with our breakdown of all the biggest news affecting shares this morning.
Via
InvestorPlace
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 18, 2024
Via
Benzinga
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
June 06, 2024
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.
Via
Benzinga
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 05, 2024
Via
Benzinga
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
June 05, 2024
Via
Benzinga
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 22, 2024
Via
Benzinga
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
May 22, 2024
Via
Benzinga
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
May 17, 2024
Via
Benzinga
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q4 2023
May 15, 2024
CVAC stock results show that CureVac missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
3 Stocks to Purge ASAP Before They’re Pulled off Life Support
May 10, 2024
Here are three stocks to sell now from your portfolio before they run out of cash and collapse. Avoid throwing good money after bad.
Via
InvestorPlace
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
May 09, 2024
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.
Via
Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
May 06, 2024
Via
Benzinga
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
April 26, 2024
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
April 12, 2024
Via
Benzinga
CureVac, GS Partner Release Data On Influenza Vaccine Study
April 04, 2024
CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen coverage with acceptable safety. Positive findings against influenza A...
Via
Benzinga
Why Biopharmaceutical Player CureVac Shares Are Rising Today
January 05, 2024
CureVac N.V. (NASDAQ: CVAC) shares are trading higher on Friday.
Via
Benzinga
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...
Via
Benzinga
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
December 19, 2023
A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) related to seeking fair compensation for infringement of a portfolio of
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.